• A Comparison of 1-Year Treatment Costs in Patients with Type 2 Diabetes Following Initiation of Insulin Glargine or Insulin Detemir in Argentina

    Dec 1, 2014, 00:00 AM

  • Introducing the New Value in Health Regional Issues Journal- The Latin America Region Edition

    Dec 1, 2014, 00:00 AM

  • The Update of the Mexican Health Care Formulary and Supply Catalog in the Context of the Health Technology Assessment

    Dec 1, 2014, 00:00 AM

  • Copyright/Subscription

    Dec 1, 2014, 00:00 AM

  • Cost-Effectiveness of Biologic Agents in the Treatment of Moderate-to-Severe Psoriasis- A Brazilian Public Health Service Perspective

    Dec 1, 2014, 00:00 AM

  • Asthma Control and Cost in Latin America

    Dec 1, 2014, 00:00 AM

  • More Doctors- Thoughts about a Controversial Health Care Policy

    Dec 1, 2014, 00:00 AM

  • Guidance Document- Global Pharmacoeconomic Model Adaption Strategies

    Dec 1, 2014, 00:00 AM

  • Reviewer Acknowledgement

    Dec 1, 2014, 00:00 AM

  • One Small Step for Latin America, One More Leap for Value in Health Regional Issues

    Dec 1, 2014, 00:00 AM

  • Análisis Costo-Utilidad Del Uso De Adalimumab, Etanercept E Infliximab Para El Tratamiento De La Artritis Psoriásica En Uruguay

    Dec 1, 2014, 00:00 AM

  • Assessment of Health Care and Economic Costs Due to Episodes of Acute Pesticide Intoxication in Workers of Rural Areas of the Coquimbo Region, Chile

    Dec 1, 2014, 00:00 AM

  • Economic Evaluation of Four Drug Administration Systems in Intensive Care Units in Colombia

    Dec 1, 2014, 00:00 AM

  • Editorial Board

    Dec 1, 2014, 00:00 AM

  • Cost-Effectiveness of the Combined Use of Warfarin and Low-Dose Aspirin versus Warfarin Alone in Egyptian Patients with Aortic Valve Replacements- A Markov Model

    Sep 1, 2014, 00:00 AM

  • Guide for Authors

    Sep 1, 2014, 00:00 AM

  • Cost-Effectiveness Comparison of Fidaxomicin and Vancomycin for Treatment of Clostridium difficile Infection- A Markov Model Based on Data from a South West Balkan Country in Socioeconomic Transition

    Sep 1, 2014, 00:00 AM

  • Table of Contents

    Sep 1, 2014, 00:00 AM

  • The Cost of Melanoma and Kidney, Prostate, and Ovarian Cancers in Russia

    Sep 1, 2014, 00:00 AM

  • Determinants of Cost-Related Nonadherence to Medications among Chronically Ill Patients in Maccabi Healthcare Services, Israel

    Sep 1, 2014, 00:00 AM

  • An Overview of the Orphan Medicines Market in Turkey

    Sep 1, 2014, 00:00 AM

  • Medical and Productivity Costs of Rheumatoid Arthritis in The Czech Republic- Cost-of-Illness Study Based on Disease Severity

    Sep 1, 2014, 00:00 AM

  • Use of the EQ-5D Instrument and Value Scale in Comparing Health States of Patients in Four Health Care Programs among Health Care Providers

    Sep 1, 2014, 00:00 AM

  • Health Care Financing in Ethiopia- Implications on Access to Essential Medicines

    Sep 1, 2014, 00:00 AM

  • Social Cost of Substance Abuse in Russia

    Sep 1, 2014, 00:00 AM

  • Cost-effectiveness versus Cost-Utility Analyses- What Are the Motives Behind Using Each and How Do Their Results Differ?—A Polish Example

    Sep 1, 2014, 00:00 AM

  • Mapping the Nottingham Health Profile onto the Preference-Based EuroQol-5D Instrument for Patients with Diabetes

    Sep 1, 2014, 00:00 AM

  • The Role of the National Health Insurance Fund Administration in the Development of Health Economics and Health Technology Assessment in Hungary

    Sep 1, 2014, 00:00 AM

  • Editorial Board

    Sep 1, 2014, 00:00 AM

  • Work Productivity and Costs Related to Patients with Ankylosing Spondylitis, Rheumatoid Arthritis, and Psoriasis

    Sep 1, 2014, 00:00 AM

  • Publisher’s Note

    Sep 1, 2014, 00:00 AM

  • Health Facility Cost of Buruli Ulcer Wound Treatment in Ghana- A Case Study

    Sep 1, 2014, 00:00 AM

  • What Are the Challenges in Conducting Cost-of-Illness Studies?

    Sep 1, 2014, 00:00 AM

  • Reviewer Acknowledgement

    Sep 1, 2014, 00:00 AM

  • Estimation of the Direct Cost of HIV-Infected Patients in Greece on an Annual Basis

    Sep 1, 2014, 00:00 AM

  • Copyright/Subscription

    Sep 1, 2014, 00:00 AM

  • Investigating the Economic Impacts of New Public Pharmaceutical Policies in Greece- Focusing on Price Reductions and Cost-Sharing Rates

    Sep 1, 2014, 00:00 AM

  • Health Economic Data Requirements and Availability in the European Union- Results of a Survey Among 10 European Countries

    Sep 1, 2014, 00:00 AM

  • Interim EQ-5D-5L Value Set for Poland- First Crosswalk Value Set in Central and Eastern Europe

    Sep 1, 2014, 00:00 AM

  • A Cost-Utility Analysis Comparing Standard Axillary Lymph Node Dissection with Sentinel Lymph Node Biopsy in Patients with Early Stage Breast Cancer in Thailand

    May 1, 2014, 00:00 AM

  • Cost-Effectiveness of Partially Hydrolyzed Whey Protein Formula in the Primary Prevention of Atopic Dermatitis in At-Risk Urban Filipino Infants

    May 1, 2014, 00:00 AM

  • Cost-Effectiveness Analysis of CT Colonography for Colorectal Cancer Screening Program to Working Age in Japan

    May 1, 2014, 00:00 AM

  • The Health Technology Assessment Environment in Mainland China, Japan, South Korea, and Taiwan—Implications for the Evaluation of Diabetes Mellitus Therapies

    May 1, 2014, 00:00 AM

  • Would It Matter to Expose Elderly Patients Who Took Digoxin to Chinese Medications?

    May 1, 2014, 00:00 AM

  • Assessment of Preference for Hormonal Treatment–Related Health States among Patients with Breast Cancer

    May 1, 2014, 00:00 AM

  • Economic Impact of Pneumococcal Protein-D Conjugate Vaccine (PHiD-CV) on the Malaysian National Immunization Programme

    May 1, 2014, 00:00 AM

  • Guide for Authors

    May 1, 2014, 00:00 AM

  • A Systematic Review on the Extent and Quality of Pharmacoeconomic Publications for China

    May 1, 2014, 00:00 AM

  • Models to Predict the Burden of Cardiovascular Disease Risk in a Rural Mountainous Region of Vietnam

    May 1, 2014, 00:00 AM

  • “Socialization of Health Care” in Vietnam- What Is It and What Are Its Pros and Cons?

    May 1, 2014, 00:00 AM

  • Cost-Effectiveness Analysis of Pneumococcal Vaccination with the Pneumococcal Polysaccharide NTHi Protein D Conjugate Vaccine in the Philippines

    May 1, 2014, 00:00 AM

  • Table of Contents

    May 1, 2014, 00:00 AM

  • Investigation of Evidence Sources for Health-Related Quality of Life in Cost-Utility Analysis of Pharmaceuticals in Japan

    May 1, 2014, 00:00 AM

  • Analysis of a Small Group of Stakeholders Regarding Advancing Health Technology Assessment in India

    May 1, 2014, 00:00 AM

  • Economic Burden of Diabetes Mellitus on Patients with Respiratory Failure Requiring Mechanical Ventilation during Hospitalizations

    May 1, 2014, 00:00 AM

  • Estimating the Cost-Effectiveness of the 7-Valent Pneumococcal Conjugate Vaccine in Shanghai, China

    May 1, 2014, 00:00 AM

  • The Patient-Related Burden of Pegylated-Interferon-α Therapy and Adverse Events among Patients with Viral Hepatitis C in Japan

    May 1, 2014, 00:00 AM

  • The Drug Reimbursement Decision-Making System in Iran

    May 1, 2014, 00:00 AM

  • Evaluation of the Psychometric Properties of the Malay Version of the Minnesota Nicotine Withdrawal Scale

    May 1, 2014, 00:00 AM

  • Assessment of Effect of Diabetes on Health-Related Quality of Life in Patients with Coronary Artery Disease Using the EQ-5D Questionnaire

    May 1, 2014, 00:00 AM

  • Cost-Effectiveness of Periodontitis Management in Public Sector Specialist Periodontal Clinics- A Societal Perspective Research in Malaysia

    May 1, 2014, 00:00 AM

  • Cost-Effectiveness of Linezolid versus Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Confirmed Nosocomial Pneumonia in China

    May 1, 2014, 00:00 AM

  • Usefulness of Patient-Generated Index for HIV to Measure Individual Quality of Life- A Study from Thailand

    May 1, 2014, 00:00 AM

  • Revisit What Is Next for Pharmacoeconomics and Outcomes Research in Asia

    May 1, 2014, 00:00 AM

  • Estimating the Long-Term Clinical and Economic Outcomes of Daclatasvir Plus Asunaprevir in Difficult-to-Treat Japanese Patients Chronically Infected with Hepatitis C Genotype 1b

    May 1, 2014, 00:00 AM

  • Cost-Utility Analysis of Home-Based Care for Treatment of Thai Hemophilia A and B

    May 1, 2014, 00:00 AM

  • Estimating the Incidence and Prevalence of Chronic Hepatitis C Infection in Taiwan Using Back Projection

    May 1, 2014, 00:00 AM

  • Reviewer Acknowledgement

    May 1, 2014, 00:00 AM

  • A Year of Significant Progress for Value in Health Regional Issues

    May 1, 2014, 00:00 AM

  • Resource Utilization and Direct Medical Costs of Chronic Hepatitis C in Thailand- A Heavy but Manageable Economic Burden

    May 1, 2014, 00:00 AM

  • Treatment Costs of Stroke Related to Nonvalvular Atrial Fibrillation Patients in India—A Multicenter Observational Study

    May 1, 2014, 00:00 AM

  • Cost-Utility Analysis of Erythropoietin for Anemia Treatment in Thai End-Stage Renal Disease Patients with Hemodialysis

    May 1, 2014, 00:00 AM

  • Comparative Analysis of Calendar Time-Specific and Conventional Propensity Score Analysis for Thiazolidinedione Use in Diabetes

    May 1, 2014, 00:00 AM

  • Epidermal Growth Factor Receptor Mutation Testing in Thailand- A Cost-Utility Analysis

    May 1, 2014, 00:00 AM

  • Editorial Board

    May 1, 2014, 00:00 AM

  • Editorial Board

    Dec 1, 2013, 00:00 AM

  • Uso del Registro de Solicitudes de Medicamentos no Incluidos en el Listado de Medicamentos Esenciales como Nueva Fuente de Información en los Sistemas Nacionales de Farmacovigilancia

    Dec 1, 2013, 00:00 AM

  • Atlas Argentino de Calidad de Vida Relacionada con la Salud- Análisis de los datos de la Encuesta Nacional de Factores de Riesgo por Provincias

    Dec 1, 2013, 00:00 AM

  • Análisis de Minimización de Costo e Impacto Presupuestario del Tratamiento ARV con Abacavir/Lamivudina para el VIH/SIDA en México

    Dec 1, 2013, 00:00 AM

  • Avaliação Econômica do Interferon Peguilado Alfa 2a em Combinação com a Ribavirina para o Tratamento da Infecção Pelo Genótipo 1 da Hepatite Crônica C- Comparação do Tratamento por 48 Semanas e Terapia Estendida

    Dec 1, 2013, 00:00 AM

  • Societal Preferences for EQ-5D Health States from a Brazilian Population Survey

    Dec 1, 2013, 00:00 AM

  • Guide for Authors

    Dec 1, 2013, 00:00 AM

  • Evaluation of the Stroke-Specific Quality-of-Life (SSQOL) Scale in Mexico- A Preliminary Approach

    Dec 1, 2013, 00:00 AM

  • Estándares Consolidados de Reporte de Evaluaciones Económicas Sanitarias- Versión en Español de la Lista de Comprobación CHEERS

    Dec 1, 2013, 00:00 AM

  • Análisis del Proceso de Actualización de Medicamentos en el Cuadro Básico y Catálogo de Insumos del Sector Salud

    Dec 1, 2013, 00:00 AM

  • Dengue Epidemiology and Burden of Disease in Latin America and the Caribbean- A Systematic Review of the Literature and Meta-Analysis

    Dec 1, 2013, 00:00 AM

  • Reviewer Acknowledgment

    Dec 1, 2013, 00:00 AM

  • Lista de Comprobación CHEERS11Consolidated Health Economic Evaluation Reporting Standards. en Españ̆ol- Estándares Consolidados de Reporte de Evaluaciones Económicas Sanitarias

    Dec 1, 2013, 00:00 AM

  • Table of Contents

    Dec 1, 2013, 00:00 AM

  • Copyright/Subscription

    Dec 1, 2013, 00:00 AM

  • Carga de la Enfermedad Atribuible al Síndrome de Túnel del Carpo en la Población Trabajadora Colombiana- Una Aproximación a los Costos Indirectos de una Enfermedad

    Dec 1, 2013, 00:00 AM

  • Costo-Efectividad de la Proteína C Reactiva, Procalcitonina y Escala de Rochester- Tres Estrategias Diagnosticas para la Identificación de Infección Bacteriana Severa en Lactantes Febriles sin Foco

    Dec 1, 2013, 00:00 AM

  • The Impact of Psychotropic Drug Costs on the Brazilian Family Budget- An Analysis of the Family Budget Surveys of 2003 and 2009

    Dec 1, 2013, 00:00 AM

  • Table of Contents

    Sep 1, 2013, 00:00 AM

  • Cost-Utility Analysis of Depot Atypical Antipsychotics for Chronic Schizophrenia in Croatia

    Sep 1, 2013, 00:00 AM

  • Impact of the Pharma Economic Act on Diffusion of Innovation and Reduction of Costs in the Hungarian Prescription Drug Market (2007–2010)

    Sep 1, 2013, 00:00 AM

  • The Methodological Challenges for the Estimation of Quality of Life in Children for Use in Economic Evaluation in Low-Income Countries

    Sep 1, 2013, 00:00 AM

  • Cost for Treatment of Chronic Lymphocytic Leukemia in Specialized Institutions of Ukraine

    Sep 1, 2013, 00:00 AM

  • Performance Assessment of Ga District Mutual Health Insurance Scheme, Greater Accra Region, Ghana

    Sep 1, 2013, 00:00 AM

  • Further Steps in the Development of Pharmacoeconomics, Outcomes Research, and Health Technology Assessment in Central and Eastern Europe, Western Asia, and Africa

    Sep 1, 2013, 00:00 AM

  • Editorial Board

    Sep 1, 2013, 00:00 AM

  • The Impact of Pharmaceutical Care Intervention on the Quality of Life of Nigerian Patients Receiving Treatment for Type 2 Diabetes

    Sep 1, 2013, 00:00 AM

  • Transforming Public Servants’ Health Care Organization in Greece through the Implementation of an Electronic Referral Project

    Sep 1, 2013, 00:00 AM

  • What Influences Recommendations Issued by the Agency for Health Technology Assessment in Poland? A Glimpse Into Decision Makers’ Preferences

    Sep 1, 2013, 00:00 AM

  • Children Hospitalized for Varicella- Complications and Cost Burden

    Sep 1, 2013, 00:00 AM

  • Guide for Authors

    Sep 1, 2013, 00:00 AM

  • Copyright/Subscription

    Sep 1, 2013, 00:00 AM

  • Clinical Burden of Invasive Pneumococcal Disease in Selected Developing Countries

    Sep 1, 2013, 00:00 AM

  • The Process of Privatization of Health Care Provision in Poland

    Sep 1, 2013, 00:00 AM

  • Patient-Reported Quality of Life During Antiretroviral Therapy in a Nigerian Hospital

    Sep 1, 2013, 00:00 AM

  • Note from the Editors

    Sep 1, 2013, 00:00 AM

  • Recommendations for Reporting Pharmacoeconomic Evaluations in Egypt

    Sep 1, 2013, 00:00 AM

  • Dossier System as a Practical Tool for Compiling Reimbursement Lists

    Sep 1, 2013, 00:00 AM

  • Cost-Utility Analysis of Pharmaceutical Care Intervention Versus Usual Care in Management of Nigerian Patients with Type 2 Diabetes

    Sep 1, 2013, 00:00 AM

  • Capacity Building for HTA Implementation in Middle-Income Countries- The Case of Hungary

    Sep 1, 2013, 00:00 AM

  • An Audit of Diabetes-Dependent Quality of Life (ADDQOL) in Older Patients with Diabetes Mellitus Type 2 in Slovenia

    Sep 1, 2013, 00:00 AM

  • Costs of Medically Attended Acute Gastrointestinal Infections- The Polish Prospective Healthcare Utilization Survey

    Sep 1, 2013, 00:00 AM

  • Radiology Services Costs and Utilization Patterns Estimates in Southeastern Europe—A Retrospective Analysis from Serbia

    Sep 1, 2013, 00:00 AM

  • Response to “Potential Regulatory and Commercial Environment for Biosimilars in Latin America” by Azevedo et al.

    Sep 1, 2013, 00:00 AM

  • Reviewer Acknowledgement

    Sep 1, 2013, 00:00 AM

  • A Framework for Applying Health Technology Assessment in Cyprus- Thoughts, Success Stories, and Recommendations

    Sep 1, 2013, 00:00 AM

  • Cost-Effectiveness Analysis of Aripiprazole Augmentation Treatment of Patients with Major Depressive Disorder Compared to Olanzapine and Quetiapine Augmentation in Turkey- A Microsimulation Approach

    Sep 1, 2013, 00:00 AM

  • Response to Letter from Dr. Jorge Revilla Beltri dated 22nd March, 2013

    Sep 1, 2013, 00:00 AM

  • Systematic Review of Economic Evaluation Literature in Ghana- Is Health Technology Assessment the Future?

    Sep 1, 2013, 00:00 AM

  • ERRATUM

    Sep 1, 2013, 00:00 AM

  • Economic Burden of Cardiovascular Diseases in the Russian Federation

    Sep 1, 2013, 00:00 AM

  • Guide for Authors

    May 1, 2013, 00:00 AM

  • Table of Contents

    May 1, 2013, 00:00 AM

  • The Health Economic Impact of Universal Infant Vaccination with the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine as Compared with 13-Valent Pneumococcal Conjugate Vaccine in Hong Kong

    May 1, 2013, 00:00 AM

  • Cost-Effectiveness Analysis of Omalizumab for the Treatment of Severe Asthma in Japan and the Value of Responder Prediction Methods Based on a Multinational Trial

    May 1, 2013, 00:00 AM

  • A Novel Estimation of the Impact of Treatment with Entecavir on Long-Term Mortality, Morbidity, and Health Care Costs of Chronic Hepatitis B in China

    May 1, 2013, 00:00 AM

  • Copyright/Subscription

    May 1, 2013, 00:00 AM

  • Cost-Effectiveness of Clinical Pharmacy Education on Infection Management among Patients with Chronic Kidney Disease in an Indonesian Hospital

    May 1, 2013, 00:00 AM

  • A Cost-Effectiveness Analysis between Amlodipine and Angiotensin II Receptor Blockers in Stroke and Myocardial Infarction Prevention among Hypertension Patients in China

    May 1, 2013, 00:00 AM

  • The Cost-Effectiveness Analysis of a Quadrivalent Human Papillomavirus Vaccine (6/11/16/18) for Females in Japan

    May 1, 2013, 00:00 AM

  • Equity in Pharmaceutical Pricing and Reimbursement- Crossing the Income Divide in Asia Pacific

    May 1, 2013, 00:00 AM

  • Assessment of Adverse Events and Quality of Life of Cancer Patients in a Secondary Level Care, Rural Hospital in South India

    May 1, 2013, 00:00 AM

  • Burden of Disease Studies in the Asia-Pacific Region- Are There Enough being Performed to Provide Information for Evidence-Based Health Policy?

    May 1, 2013, 00:00 AM

  • What Is Important During the Selection of Traditional Chinese Medicine (TCM) in a Health Care Reimbursement or Insurance System?” Critical Issues of Assessment from the Perspective of TCM Practitioners

    May 1, 2013, 00:00 AM

  • Reviewer Acknowledgment

    May 1, 2013, 00:00 AM

  • Emerging Hub for Pharmacoeconomics and Outcomes Research- Asia-Pacific Region

    May 1, 2013, 00:00 AM

  • Economic Evaluation of Pravastatin for Primary Prevention of Coronary Artery Disease Based on Risk Prediction from JALS-ECC in Japan

    May 1, 2013, 00:00 AM

  • Economic Evaluation of Lipid-Lowering Therapy in the Secondary Prevention Setting in the Philippines

    May 1, 2013, 00:00 AM

  • Assessment of Costs Associated with Hospital-Acquired Infections in a Private Tertiary Care Hospital in India

    May 1, 2013, 00:00 AM

  • Economic Burden of Individual Suffering from Atrial Fibrillation–Related Stroke in China

    May 1, 2013, 00:00 AM

  • Epidemiology and Disease Burden of Ulcerative Colitis in Taiwan- A Nationwide Population-Based Study

    May 1, 2013, 00:00 AM

  • Clinical Characterization and the Caregiver Burden of Dementia in China

    May 1, 2013, 00:00 AM

  • Cost-Effectiveness Analysis of a Screening Program for Breast Cancer in Vietnam

    May 1, 2013, 00:00 AM

  • Increasing Anti-Infective Drug Expenditure in Tianjin, China- A Decomposition Analysis

    May 1, 2013, 00:00 AM

  • Economic Impact of Venous Thromboembolism Following Major Orthopaedic Surgery in Japan

    May 1, 2013, 00:00 AM

  • Editorial Board

    May 1, 2013, 00:00 AM

  • Health-Related Quality of Life among Nonprescription Medicine Customers in Malaysia

    May 1, 2013, 00:00 AM

  • Validity and Reliability of KDQOL-36 in Thai Kidney Disease Patient

    May 1, 2013, 00:00 AM

  • Future Prospects for Pharmacoeconomics and Outcomes Research in the Emerging Regions

    May 1, 2013, 00:00 AM

  • The Factors Contributing to Expenditures on Over-the-Counter Drugs in South Korea

    May 1, 2013, 00:00 AM

  • Analysis of Excess Direct Medical Costs of Vision Impairment in Taiwan

    May 1, 2013, 00:00 AM

  • Burden of Disease and Economic Impact of Dengue and Severe Dengue in Colombia, 2011

    Dec 1, 2012, 00:00 AM

  • An Estimate of the Cost of Hepatitis C Treatment for the Brazilian Health System

    Dec 1, 2012, 00:00 AM

  • Economic Burden of Incident Unplanned Starts on Peritoneal Dialysis in a High Specialty Health Care Facility in Mexico City

    Dec 1, 2012, 00:00 AM

  • Guide for Authors

    Dec 1, 2012, 00:00 AM

  • Table of Contents

    Dec 1, 2012, 00:00 AM

  • Reviewer Acknowledgement

    Dec 1, 2012, 00:00 AM

  • Status Update of the Reimbursement Review Environment in the Public Sector across Four Latin American Countries

    Dec 1, 2012, 00:00 AM

  • Editorial Board

    Dec 1, 2012, 00:00 AM

  • Colombian Health System on its Way to Improve Allocation Efficiency—Transition from a Health Sector Reform to the Settlement of an HTA Agency

    Dec 1, 2012, 00:00 AM

  • Impacto de Dos Métodos Alternativos de Asignación de Costos Indirectos Estructurales de Hospitales Públicos Chilenos en el Costo Final de Producción de Servicios Sanitarios

    Dec 1, 2012, 00:00 AM

  • Consideraciones Regulatorias sobre Productos Biológicos en Brasil

    Dec 1, 2012, 00:00 AM

  • Cost Utility of Sirolimus versus Tacrolimus for the Primary Prevention of Graft Rejection in Renal Transplant Recipients in Mexico

    Dec 1, 2012, 00:00 AM

  • The Cost-Effectiveness and Budget Impact of Introducing Indacaterol into the Colombian Health System

    Dec 1, 2012, 00:00 AM

  • Costo Efectividad del Tratamiento de Tumores Neuroendócrinos Pancreáticos Avanzados no Operables con Sunitinib en México

    Dec 1, 2012, 00:00 AM

  • Análisis de Costo-Efectividad de las Estrategias de Tamización de Cáncer Colorrectal en Colombia

    Dec 1, 2012, 00:00 AM

  • Potential Regulatory and Commercial Environment for Biosimilars in Latin America

    Dec 1, 2012, 00:00 AM

  • Economic Evaluation of Bariatric Surgery in Mexico Using Discrete Event Simulation

    Dec 1, 2012, 00:00 AM

  • Criterios Farmacoeconómicos Usados en México para la Evaluación de Tratamientos en Personas en Fases Terminales

    Dec 1, 2012, 00:00 AM

  • Institutionalizing Health Technology Assessment in Brazil- Challenges Ahead

    Dec 1, 2012, 00:00 AM

  • Cost-Effectiveness of Routine Screening for Cardiac Toxicity in Patients Treated with Imatinib in Brazil

    Dec 1, 2012, 00:00 AM

  • Bloodstream Infection in the Intensive Care Unit- Preventable Adverse Events and Cost Savings

    Dec 1, 2012, 00:00 AM

  • Performing Country-led Economic Evaluations to Inform Immunization Policy- ProVac Experiences in Latin America and the Caribbean

    Dec 1, 2012, 00:00 AM

  • Análisis Costo Efectividad del Stent Farmacológico V/S Stent no Farmacológico en Cardiopatía Isquémica en Chile

    Dec 1, 2012, 00:00 AM

  • Diferenciación en la Evaluación Económica Tradicional para Medicamentos que se Utilizan en Fases Terminales, Recomendaciones Recientes del Reino Unido y su Consideración para México y otros Países

    Dec 1, 2012, 00:00 AM

  • Concurrent Validity and Reliability of the Brazilian Version of the Functioning Assessment Short Test in Patients with Schizophrenia

    Dec 1, 2012, 00:00 AM

  • Copyright/Subscription

    Dec 1, 2012, 00:00 AM

  • Prevalence, Awareness, Treatment, and Burden of Major Depressive Disorder- Estimates from the National Health and Wellness Survey in Brazil

    Dec 1, 2012, 00:00 AM

  • Análisis de Costo Efectividad de Estrategias de Tratamiento Antimicótico en Pacientes con Neutropenia Febril Persistente y Tratamiento Antibiótico de Amplio Espectro

    Dec 1, 2012, 00:00 AM

  • Economic Evaluation of Rehabilitation Services for Inpatients with Stroke in Thailand- A Prospective Cohort Study

    May 1, 2012, 00:00 AM

  • Attributable Cost and Length of Stay for Patients with Enoxaparin-Associated Bleeding

    May 1, 2012, 00:00 AM

  • The Cost of Providing HIV/AIDS Counseling and Testing Services in Vietnam

    May 1, 2012, 00:00 AM

  • How Does Out-of-Pocket Payment Affect Choices When Accessing Health Care?—A Qualitative Study on Hypertensive Outpatients in Southern Taiwan

    May 1, 2012, 00:00 AM

  • Copyright/Subscription

    May 1, 2012, 00:00 AM

  • Generalized Cost-Effectiveness Analysis of Pharmaceutical Interventions for Primary Prevention of Cardiovascular Disease in Thailand

    May 1, 2012, 00:00 AM

  • Health State Utility Assessment for Breast Cancer

    May 1, 2012, 00:00 AM

  • Validation of the Schizophrenia Quality of Life Scale Revision 4 among Chronic Schizophrenia Patients in Malaysia

    May 1, 2012, 00:00 AM

  • Are English and Chinese Versions of the Audit of Diabetes-Dependent Quality of Life Equivalent? An Exploratory Study Based on the Universalist Approach

    May 1, 2012, 00:00 AM

  • Cost of Illness of Chronic Hepatitis B Infection in Vietnam

    May 1, 2012, 00:00 AM

  • Patient Utility Measurement for Managing Ureteral Stones- A Modified Standard Gamble Approach

    May 1, 2012, 00:00 AM

  • Editorial Board

    May 1, 2012, 00:00 AM

  • Table of Contents

    May 1, 2012, 00:00 AM

  • Reconciling Cancer Care Costs Reported by Different Government Agencies in Taiwan- Why Costing Approach Matters?

    May 1, 2012, 00:00 AM

  • Reviewer Acknowledgment

    May 1, 2012, 00:00 AM

  • Cost-Effectiveness Analysis of Hepatitis B Immunization in Vietnam- Application of Cost-Effectiveness Affordability Curves in Health Care Decision Making

    May 1, 2012, 00:00 AM
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10 (current)
  • »